Literature DB >> 16699525

Negative regulation of interferon-regulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1.

Tatsuya Saitoh1, Adrian Tun-Kyi, Akihide Ryo, Masahiro Yamamoto, Greg Finn, Takashi Fujita, Shizuo Akira, Naoki Yamamoto, Kun Ping Lu, Shoji Yamaoka.   

Abstract

Recognition of double-stranded RNA activates interferon-regulatory factor 3 (IRF3)-dependent expression of antiviral factors. Although the molecular mechanisms underlying the activation of IRF3 have been studied, the mechanisms by which IRF3 activity is reduced have not. Here we report that activation of IRF3 is negatively regulated by the peptidyl-prolyl isomerase Pin1. After stimulation by double-stranded RNA, induced phosphorylation of the Ser339-Pro340 motif of IRF3 led to its interaction with Pin1 and finally polyubiquitination and then proteasome-dependent degradation of IRF3. Suppression of Pin1 by RNA interference or genetic deletion resulted in enhanced IRF-3-dependent production of interferon-beta, with consequent reduction of virus replication. These results elucidate a previously unknown mechanism for controlling innate antiviral responses by negatively regulating IRF3 activity via Pin1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16699525     DOI: 10.1038/ni1347

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  141 in total

1.  Arterivirus and nairovirus ovarian tumor domain-containing Deubiquitinases target activated RIG-I to control innate immune signaling.

Authors:  Puck B van Kasteren; Corrine Beugeling; Dennis K Ninaber; Natalia Frias-Staheli; Sander van Boheemen; Adolfo García-Sastre; Eric J Snijder; Marjolein Kikkert
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  A functional C-terminal TRAF3-binding site in MAVS participates in positive and negative regulation of the IFN antiviral response.

Authors:  Suzanne Paz; Myriam Vilasco; Steven J Werden; Meztli Arguello; Deshanthe Joseph-Pillai; Tiejun Zhao; Thi Lien-Anh Nguyen; Qiang Sun; Eliane F Meurs; Rongtuan Lin; John Hiscott
Journal:  Cell Res       Date:  2011-01-04       Impact factor: 25.617

3.  Characterization of a spliced variant of human IRF-3 promoter and its regulation by the transcription factor Sp1.

Authors:  Wei Ren; Liang-Hua Zhu; Hua-Guo Xu; Rui Jin; Guo-Ping Zhou
Journal:  Mol Biol Rep       Date:  2012-02-04       Impact factor: 2.316

Review 4.  Self-regulation and cross-regulation of pattern-recognition receptor signalling in health and disease.

Authors:  Xuetao Cao
Journal:  Nat Rev Immunol       Date:  2016-01       Impact factor: 53.106

5.  A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3.

Authors:  Alexa C Robitaille; Mélissa K Mariani; Audray Fortin; Nathalie Grandvaux
Journal:  J Vis Exp       Date:  2016-01-24       Impact factor: 1.355

6.  TLR-7 Stress Signaling in Differentiating and Mature Eosinophils Is Mediated by the Prolyl Isomerase Pin1.

Authors:  Zhong-Jian Shen; Jie Hu; Venkatesh Kashi; Yury A Bochkov; James E Gern; James S Malter
Journal:  J Immunol       Date:  2018-11-05       Impact factor: 5.422

7.  Recruitment of activated IRF-3 and CBP/p300 to herpes simplex virus ICP0 nuclear foci: Potential role in blocking IFN-beta induction.

Authors:  Gregory T Melroe; Lindsey Silva; Priscilla A Schaffer; David M Knipe
Journal:  Virology       Date:  2006-11-28       Impact factor: 3.616

Review 8.  Peptidyl-prolyl cis/trans isomerases and transcription: is there a twist in the tail?

Authors:  Peter E Shaw
Journal:  EMBO Rep       Date:  2007-01       Impact factor: 8.807

Review 9.  Innate antiviral immune signaling, viral evasion and modulation by HIV-1.

Authors:  Arjun Rustagi; Michael Gale
Journal:  J Mol Biol       Date:  2013-12-08       Impact factor: 5.469

10.  Aryl Hydrocarbon Receptor Interacting Protein Targets IRF7 to Suppress Antiviral Signaling and the Induction of Type I Interferon.

Authors:  Qinjie Zhou; Alfonso Lavorgna; Melissa Bowman; John Hiscott; Edward W Harhaj
Journal:  J Biol Chem       Date:  2015-04-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.